First Graphene Limited has secured its first purchase order from US-based Flux Footwear to supply PureGRAPH® graphene material for Flux's athletic and leisure shoes. This marks First Graphene's entry into the global sports footwear market, valued at over US$150 billion, expanding from its previous work in industrial and safety footwear. The graphene-enhanced shoes will benefit from improved durability, abrasion resistance, and performance, aligning with growing consumer demand for longer-lasting, high-performance footwear. This order establishes a commercial pathway for recurring revenue and expands First Graphene's presence in the US market.
The story on First Graphene Limited's PureGRAPH® production order provides context for readers interested in consumer cyclical stocks. For readers following this sector, here is Pluang's market snapshot as of Oct 07, 2026 05:51 WIB: Out of 112 priced US consumer cyclical stocks, 69 rose and 41 fell today. Among notable movers, Lennar Corporation (LEN) rose 4.37% to USD 77.69 with a typical hold time of 67 days and a Pluang order activity of 77% Buy, contrasting with Abercrombie & Fitch Co. (ANF) which rose 4.09% to USD 141.47 but had 84% Sell orders. Carnival Corp (CCL) gained 3.99% to USD 26.58 with a 100% Buy order activity and a longer typical hold time of 106 days.
Dogecoin's price rose 1.2% to $0.094, marking its first daily golden cross in 14 months, a bullish signal indicating improving short-term momentum. However, the cryptocurrency faces strong resistance near $0.10, a level it must surpass to confirm a s...
Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...
U.S. spot Solana ETFs experienced $3.7 million in net outflows on October 6, marking the second consecutive day of withdrawals. The Grayscale Solana Trust was the main contributor to this decline, while six other funds showed no net flow. Although th...
Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...
On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...
